Point to Consider in Non-Clinical Studies on Each Category of Biotechnology-Derived Pharmaceuticals.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF NON-CLINICAL STUDIES ON BIO-PHARMACEUTICALS(CURENT SURVEY))
スポンサーリンク
概要
著者
-
Koga Tomoko
Japan Pharmaceutical Manufacturers Association:novartis Pharma K.k.
-
KADOTA TOSHIHITO
Japan Pharmaceutical Manufacturers Association
-
HORIGOME HIROAKI
Japan Pharmaceutical Manufacturers Association
-
Kadota Toshihito
Japan Pharmaceutical Manufacturers Association:nippon Boehringer Ingelheim Co. Ltd.
-
Horigome Hiroaki
Japan Pharmaceutical Manufacturers Association:novo Nordisk Pharma Ltd.
関連論文
- Questionnaire survey of application in S7A Safety Pharmacology Guideline (Part 2) : Point of GLP (STATISTICAL METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Questionnaire survey of application in S7A Safety Pharmacology Guideline (Part 1) : Point of experimental items (STATISTICAL METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Point to Consider in Non-Clinical Studies on Each Category of Biotechnology-Derived Pharmaceuticals.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF NON-CLINICAL STUDIES ON BIO-PHARMACEUTICALS(CURENT SURVEY))
- P8-48 Questionnaire Survey about GLP Requirements for Safety Pharmacology(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)